Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuji Wang

Showing results (81-90 of 221) with videos related to

Pageof 23
Sort By:
Oncotarget|December 7, 2017
IQCA-TAVV: To explore the effect of P-selectin, GPIIb/IIIa, IL-2, IL-6 and IL-8 on deep venous thrombosisJianhui Wu, Haimei Zhu, Guodong Yang, et al.
Journal of Materials Chemistry. B|April 9, 2020
Cholyl-l-lysine-carboxylbutyryl adriamycin prodrugs targeting chemically induced liver injuryHaiping Ma, Ming Zhao, Yuji Wang, et al.
European Journal of Medicinal Chemistry|October 11, 2011
A class of novel N-(1-methyl-β-carboline-3-carbonyl)-N'-(aminoacid-acyl)-hydrazines: aromatization leaded design, synthesis, in vitro anti-platelet aggregation/in vivo anti-thrombotic evaluation and 3D QSAR analysisChunyu Li, Xiaoyi Zhang, Ming Zhao, et al.
European Journal of Medicinal Chemistry|July 8, 2023
Highly-tumor-targeted PAD4 inhibitors with PBA modification inhibit tumors in vivo by specifically inhibiting the PAD4-H3cit-NETs pathway in neutrophilsDi Zhu, Yu Lu, Bo Hu, et al.
Nanoscale|June 17, 2026
AI-guided design of self-assembled flavonoid-cisplatin nanoparticles enhances triple-negative breast cancer therapy <i>via</i> three cell-death pathwaysMarMar Tuohan, Geng Hu, Di Zhu, et al.
Pharmaceutical Biology|October 6, 2022
Genistein-induced mitochondrial dysfunction and FOXO3a/PUMA expression in non-small lung cancer cellsLiujia Chan, Yuheng Pang, Yuji Wang, et al.
European Journal of Medicinal Chemistry|August 24, 2022
(1R,3S)-THCCA-Asn: To show the discovery of selective inhibitor of thrombin by successfully combining virtual screening and biological assayXiaoyi Zhang, Yifan Yang, Yuji Wang, et al.
Chemical & Pharmaceutical Bulletin|August 24, 2022
Synthesis and Evaluation of a Paclitaxel-Binding Tripeptide Micelle for Lung Cancer TherapyJie Gao, Yijiang Jia, Taledaohan Ayijiang, et al.
Molecular Biosystems|March 16, 2011
HPLC-MS aided PC12 cell systems: to quantitatively monitor the conversion of nitronyl nitroxide in biological systems with and without NOYuji Wang, Xueyun Jiang, Jiawang Liu, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|January 18, 2012
pH-Dependent nanostructure based on isoquinoline-cyclodextrin conjugate for thrombosis therapyLi Li, Ming Zhao, Wenhao Li, et al.
Pageof 23

Showing results (81-90 of 221) with videos related to

Sort By:
Pageof 23
Oncotarget|December 7, 2017
IQCA-TAVV: To explore the effect of P-selectin, GPIIb/IIIa, IL-2, IL-6 and IL-8 on deep venous thrombosisJianhui Wu, Haimei Zhu, Guodong Yang, et al.
Journal of Materials Chemistry. B|April 9, 2020
Cholyl-l-lysine-carboxylbutyryl adriamycin prodrugs targeting chemically induced liver injuryHaiping Ma, Ming Zhao, Yuji Wang, et al.
European Journal of Medicinal Chemistry|October 11, 2011
A class of novel N-(1-methyl-β-carboline-3-carbonyl)-N'-(aminoacid-acyl)-hydrazines: aromatization leaded design, synthesis, in vitro anti-platelet aggregation/in vivo anti-thrombotic evaluation and 3D QSAR analysisChunyu Li, Xiaoyi Zhang, Ming Zhao, et al.
European Journal of Medicinal Chemistry|July 8, 2023
Highly-tumor-targeted PAD4 inhibitors with PBA modification inhibit tumors in vivo by specifically inhibiting the PAD4-H3cit-NETs pathway in neutrophilsDi Zhu, Yu Lu, Bo Hu, et al.
Nanoscale|June 17, 2026
AI-guided design of self-assembled flavonoid-cisplatin nanoparticles enhances triple-negative breast cancer therapy <i>via</i> three cell-death pathwaysMarMar Tuohan, Geng Hu, Di Zhu, et al.
Pharmaceutical Biology|October 6, 2022
Genistein-induced mitochondrial dysfunction and FOXO3a/PUMA expression in non-small lung cancer cellsLiujia Chan, Yuheng Pang, Yuji Wang, et al.
European Journal of Medicinal Chemistry|August 24, 2022
(1R,3S)-THCCA-Asn: To show the discovery of selective inhibitor of thrombin by successfully combining virtual screening and biological assayXiaoyi Zhang, Yifan Yang, Yuji Wang, et al.
Chemical & Pharmaceutical Bulletin|August 24, 2022
Synthesis and Evaluation of a Paclitaxel-Binding Tripeptide Micelle for Lung Cancer TherapyJie Gao, Yijiang Jia, Taledaohan Ayijiang, et al.
Molecular Biosystems|March 16, 2011
HPLC-MS aided PC12 cell systems: to quantitatively monitor the conversion of nitronyl nitroxide in biological systems with and without NOYuji Wang, Xueyun Jiang, Jiawang Liu, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|January 18, 2012
pH-Dependent nanostructure based on isoquinoline-cyclodextrin conjugate for thrombosis therapyLi Li, Ming Zhao, Wenhao Li, et al.
Pageof 23